Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | HBB | P68871 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | HTR1A | P08908 | 7/20 | 0.34 |
| ▸ | HTR7 | P34969 | 7/20 | 0.34 |
| ▸ | HTR6 | P50406 | 7/20 | 0.34 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.31 |
| ▸ | DHFR | P00374 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11331039 | 0.91 | TP53 (0.35) | TP53HBBSMN1; SMN2HTR1AHTR7 | |
| SCHEMBL7536756 | 0.89 | TP53 (0.38) | TP53HBBSMN1; SMN2HTR1AHTR7 | |
| SCHEMBL261620 | 0.89 | TP53 (0.42) | TP53HBBSMN1; SMN2HTR1AHTR7 | |
| SCHEMBL11756952 | 0.87 | TP53 (0.41) | TP53HBBSMN1; SMN2HTR1AHTR7 | |
| SCHEMBL11342172 | 0.87 | TSHR (0.41) | TP53HBBSMN1; SMN2HTR1AHTR7 | |
| SCHEMBL24507049 | 0.84 | TP53 (0.39) | TP53HBBSMN1; SMN2HTR1AHTR7 | |
| SCHEMBL11390391 | 0.83 | TSHR (0.37) | TP53HBBSMN1; SMN2HTR1AHTR7 | |
| SCHEMBL10754802 | 0.83 | RAB9A (0.34) | TP53HBBSMN1; SMN2RAB9A | |
| SCHEMBL11824827 | 0.82 | NR1H2 (0.30) | HTR1AHTR7HTR6 | |
| SCHEMBL11827895 | 0.81 | TP53 (0.32) | TP53HBBSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114981332-B | Two-part curable composition | 汉高股份有限及两合公司 | 2024-12-31 | — | — | CN | disclosed |